Dupilumab an Option When Other Targeted Agents Fail in Aspirin-Exacerbated Respiratory Disease
NEW YORK (Reuters Health) – Dupilumab, a monoclonal antibody targeting interleukin-4 (IL-4) re...
Bronchial Thermoplasty Benefits for Uncontrolled Asthma Sustained at 10 Years
NEW YORK (Reuters Health) – The benefits of ...